Literature DB >> 25343091

Study and analysis of the state of rare disease research in Shandong Province, China.

Heng Zhao1, Yazhou Cui2, Xiaoyan Zhou2, Jingxiang Pang2, Xiumei Zhang3, Shuangqing Xu2, Jinxiang Han2.   

Abstract

As the world's most populous country, China has the world's largest number of rare disease groups in terms of prevalence. However, the country has no system of registering cases of most rare diseases, so there is very little documented information on the epidemiology of those diseases. The purpose of this study was to study the state of rare disease research and survey doctors in Shandong Province regarding their level of awareness of rare diseases. Types of rare diseases and numbers of cases were tallied and their geographical distribution over the decades was analyzed. Eight hundred and twenty-four doctors in tertiary hospitals and maternity and child care hospitals were surveyed by questionnaire. Data were descriptively analyzed and a map of disease distribution was created. Articles about rare diseases were retrieved from the Chinese Biomedical Literature Database to provide pertinent data. This study yielded 5,749 cases of 323 different types of rare diseases. The survey found that doctors lack awareness of research on rare diseases. An authoritative and information-rich platform for rare disease research is urgently needed. Key steps are to study epidemiological and statistical techniques and then obtain available data to provide a basis for the definition and regulation of rare diseases in China.

Entities:  

Keywords:  Rare diseases; awareness survey; descriptive analysis

Year:  2012        PMID: 25343091      PMCID: PMC4204566          DOI: 10.5582/irdr.2012.v1.4.161

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  10 in total

1.  Intractable and rare diseases research in Asia.

Authors:  Peipei Song; Jianjun Gao; Yoshinori Inagaki; Norihiro Kokudo; Wei Tang
Journal:  Biosci Trends       Date:  2012-04       Impact factor: 2.400

2.  Adopting an orphan.

Authors:  Andrea Rinaldi
Journal:  EMBO Rep       Date:  2005-06       Impact factor: 8.807

3.  Rare diseases and orphan drugs.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2006-03       Impact factor: 4.335

4.  Orphan drug legislation: lessons for neglected tropical diseases.

Authors:  Stefano Villa; Amelia Compagni; Michael R Reich
Journal:  Int J Health Plann Manage       Date:  2009 Jan-Mar

5.  Rare diseases and legislation in China.

Authors:  Jing-Bo Wang; Jeff J Guo; Li Yang; Yan-De Zhang; Zhao-Qi Sun; Yan-Jun Zhang
Journal:  Lancet       Date:  2010-02-27       Impact factor: 79.321

6.  China's first rare-disease registry is under development.

Authors:  Yan-Jun Zhang; Yi-Ou Wang; Liang Li; Jeff J Guo; Jing-Bo Wang
Journal:  Lancet       Date:  2011-08-27       Impact factor: 79.321

Review 7.  Rare diseases, orphan drugs, and their regulation in Asia: Current status and future perspectives.

Authors:  Peipei Song; Jianjun Gao; Yoshinori Inagaki; Norihiro Kokudo; Wei Tang
Journal:  Intractable Rare Dis Res       Date:  2012-02

Review 8.  Rare diseases research in China: Opportunities, challenges, and solutions.

Authors:  Jinxiang Han; Yazhou Cui; Xiaoyan Zhou
Journal:  Intractable Rare Dis Res       Date:  2012-02

Review 9.  Orphan drugs: legal aspects, current situation.

Authors:  A Lavandeira
Journal:  Haemophilia       Date:  2002-05       Impact factor: 4.287

Review 10.  Rare diseases and orphan drugs.

Authors:  Domenica Taruscio; Fiorentino Capozzoli; Claudio Frank
Journal:  Ann Ist Super Sanita       Date:  2011       Impact factor: 1.663

  10 in total
  5 in total

Review 1.  Idiopathic pulmonary fibrosis: The current status of its epidemiology, diagnosis, and treatment in China.

Authors:  Haibo Huang; Xiaonu Peng; Chongwen Zhong
Journal:  Intractable Rare Dis Res       Date:  2013-08

2.  Defining rare diseases in China.

Authors:  Yazhou Cui; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2017-05

Review 3.  Current situation and prospects of newborn screening and treatment for Phenylketonuria in China - compared with the current situation in the United States, UK and Japan.

Authors:  Lin Mei; Peipei Song; Norihiro Kokudo; Lingzhong Xu; Wei Tang
Journal:  Intractable Rare Dis Res       Date:  2013-11

Review 4.  Incidence and prevalence of 121 rare diseases in China: Current status and challenges: 2022 revision.

Authors:  Yanqin Lu; Qingxia Gao; Xiuzhi Ren; Junfeng Li; Dan Yang; Zijian Zhang; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2022-08

5.  Current status and trend of clinical development of orphan drugs in China.

Authors:  Ziling Xiang; Wengao Jiang; Bo Yan; Junhao Jiang; Hang Zheng
Journal:  Orphanet J Rare Dis       Date:  2022-07-27       Impact factor: 4.303

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.